Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  NASDAQ OMX COPENHAGEN  >  Novo Nordisk A/S    NOVO B   DK0060534915

NOVO NORDISK A/S (NOVO B)
Mes dernières consult.
Most popular
  Report  
Real-time Quote. Real-time Cboe Europe - 06/20 09:42:13 am
285.2 DKK   -0.97%
09:49aNOVO NORDISK A/ : - Share repurchase programme
AQ
06/18SMART INSULIN P : key players in the Global Smart Insulin Pens marke..
AQ
06/14NOVO NORDISK A/ : Comeback of a rising trend ?
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
OFFRE ETE Zonebourse : Jusqu'à 6 mois offerts sur tous les portefeuilles
Quotes 5-day view   Delayed Quote. Delayed Nasdaq Omx Copenhagen
06/14/2018 06/15/2018 06/18/2018 06/19/2018 06/20/2018 Date
285.9(c) 286.85(c) 287.5(c) 288(c) 285.4 Last
2 756 626 5 756 213 2 221 430 2 202 734 390 368 Volume
+1.10% +0.33% +0.23% +0.17% -0.90% Change
More quotes
Financials (DKK)
Sales 2018 111 B
EBIT 2018 47 358 M
Net income 2018 39 127 M
Finance 2018 15 305 M
Yield 2018 2,80%
Sales 2019 116 B
EBIT 2019 49 667 M
Net income 2019 39 356 M
Finance 2019 16 502 M
Yield 2019 2,91%
P/E ratio 2018 17,90
P/E ratio 2019 17,43
EV / Sales2018 4,79x
EV / Sales2019 4,56x
Capitalization 547 B
More Financials
Company
Novo Nordisk A/S is a healthcare company, which engages in the research, development, manufacture, and marketing of pharmaceutical products.It operates through the following business segments: Diabetes & Obesity Care, and Biopharmaceuticals.The Diabetes & Obesity Care segment covers products for... 
Sector
Pharmaceuticals
Calendar
06/25 | 01:00amPresentation
More about the company
Surperformance© ratings of Novo Nordisk A/S
Trading Rating : Investor Rating :
More Ratings
Latest news on NOVO NORDISK A/S
01:07pNOVO NORDISK A/S : Team Novo Nordisk Announces Partnership with Dexcom - the Glo..
AQ
09:49aNOVO NORDISK A/S : - Share repurchase programme
AQ
06/18SMART INSULIN PENS TO GROW AT A CAGR : key players in the Global Smart Insulin P..
AQ
06/16NOVO NORDISK A/S : Leading Health Organizations Collaborate With Industry on New..
AQ
06/15NOVO NORDISK A/S : Keynote Speakers Announced for 2018 Annual Meeting & Expo
AQ
06/13NOVO NORDISK A/S : - Share repurchase programme
AQ
06/13NOVO NORDISK A/S : 2018 ISPE Annual Meeting & Expo Keynote Speakers Announced
AQ
06/11NOVO NORDISK A/S : - Share repurchase programme
AQ
06/08NOVO NORDISK A/S : Drops on Prospective Layoffs
AQ
06/08NOVO NORDISK A/S : shares fall after report of layoffs
RE
More news
Sector news : Pharmaceuticals - NEC
02:31pMERCK : to Distribute HistoCyte Laboratories Products
DJ
02:01pAlexion Uses FDA Priority-Review Voucher for Blood Disorder
DJ
10:02aRoche to Pay $2.4 Billion for Full Control of Foundation Medicine -- 2nd Upda..
DJ
09:51aRoche pays $2.4 billion for rest of cancer expert Foundation Medicine
RE
09:25aPEUGEOT : Sanofi poaches former PSA finance boss Chasseloup de Chatillon
RE
More sector news : Pharmaceuticals - NEC
4-Traders Strategies on NOVO NORDISK A/S 
NOVO NORDISK A/S - 06/14
Comeback of a rising trend ?
BUY
More Strategies
Latest Tweets
02:44pNovo Nordisk, Electro Scientific and Ituran are 3 stocks that boast high prof.. 
06/18Innate Pharma $IPH.pa to participate in the Citi 2018 European Healthcare Con.. 
06/18$NOVO B Nordisk A/S B Novo Nordisk (Buy, TP: DKK410.00) - PIONEER update at .. 
06/12Denmark is represented by pharmaceuticals giant Novo Nordisk in our 2018 Saxo.. 
06/12Saxo Equity World Cup: Novo Nordisk to eclipse Ecopetrol for victory?  
More tweets
Qtime:80
News from SeekingAlpha
06/12Xeris Pharmaceuticals To Raise $75 Million In IPO 
06/11IMF JUNE BUYS : The 16 Stocks Added To My Fund 
06/10Dividend Income Update May 2018 
06/09RETIREMENT : The Future-Proof Portfolio For Young Investors, Bought At A Market .. 
06/08NASH players in spotlight on Bristol-Myers Squibb interest 
Chart NOVO NORDISK A/S
Duration : Period :
Novo Nordisk A/S Technical Analysis Chart | NOVO B | DK0060534915 | 4-Traders
Technical analysis trends NOVO NORDISK A/S
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 28
Average target price 326  DKK
Spread / Average Target 13%
EPS Revisions
Managers
NameTitle
Lars Fruergaard Jørgensen President & Chief Executive Officer
Helge Lund Chairman
Maziar Mike Doustdar Executive Vice President-International Operations
Karsten Munk Knudsen Chief Financial Officer
Mads Krogsgaard Thomsen Chief Science Officer & Executive Vice President
Sector and Competitors
1st jan.Capitalization (M$)
NOVO NORDISK A/S-14.25%85 281
JOHNSON & JOHNSON-12.25%328 858
PFIZER0.39%212 690
NOVARTIS-8.25%193 330
ROCHE HOLDING LTD.-14.81%184 168
MERCK AND COMPANY8.39%166 880